Improving Access, Affordability and Adherence
We apply our expertise to initiatives and services designed to help patients with access, affordability and adherence.
Our Partners
Navigating Healthcare Together
We know that our purpose of Advancing Health Outcomes for All® is, and will remain, a team effort. That’s why our businesses proactively engage with our partners — biopharma companies, care providers, pharmacies, manufacturers, governments and others — to deliver insights, products and services that positively impact health.
Advancing Health Equity in Oncology
As we strive to make a world without cancer a reality, we continue to help oncologists provide their patients with the treatment, care and support they need.
Partnering with Our Government
Offering our unique perspective and expertise, we collaborate with policymakers, elected officials and other stakeholders for the benefit of patients everywhere.
Broadening Our Approach to Supplier Relationships
We seek to source high-quality products and services from a wide range of suppliers and contractors.
Bringing Access to One Patient at a Time: Noah’s Story
When doctors told Tanasha she needed to bring her four-year-old son, Noah, across the country for an open-heart surgery to treat his rare heart condition, she faced a daunting problem: getting Noah — whose condition couldn’t tolerate air travel — from their home in Spokane, WA to Boston, MA.
McKesson Medical-Surgical played a crucial role in providing the necessary medical supplies needed to support Noah’s cross-country journey, springing into action and showing genuine care for his wellbeing along the way.
Improving Access, Affordability and Adherence
We apply our expertise to initiatives and services designed to help patients with access, affordability and adherence. We also seek partnerships to understand and address the many factors that create barriers and hinder patient access to the medications they need. We do this by:
Distributing supplies, services and solutions
Increasing patient access through community pharmacies
Creating prescription access, affordability and adherence solutions
Investing in startups to advance patient outcomes
Advancing Health Equity in Oncology
Cancer touches people of all ages, genders, locations, races and ethnicities. These factors, along with other social determinants of health, can impact a patient’s treatment. As we work toward a world without cancer, we remain committed to helping oncologists deliver the treatment, care and support their patients need.
Improving patient outcomes and increasing diversity in clinical trials
We are expanding access to potentially lifesaving oncology medication and clinical trial opportunities at the community level through our joint venture with HCA Healthcare, which has combined US Oncology Research with Sarah Cannon Research Institute (SCRI) under the SCRI brand.
We're using our subject matter expertise and technology to better understand and mitigate some of the hurdles that patients can face in enrollment and ongoing participation in trials. To help reduce health disparities and enhance trial representation, we are advancing economic opportunities to foster participation for individuals from all backgrounds.
Supporting Our Government
As a global healthcare leader, we are subject to a wide range of complex and evolving regulatory requirements. Offering our unique perspective, we seek to educate elected and appointed officials about the solutions we offer to enhance patient safety, reduce costs and improve healthcare delivery.
We bring deep expertise in pharmaceutical distribution, supply chain analytics and market access dynamics to our public policy efforts — and we remain committed to applying that knowledge to serve providers and improve patient outcomes.
As part of this commitment, we invite all stakeholders — including distributors, manufacturers, payers, pharmacies, providers and government partners — to learn more about our advocacy and partnerships to address drug shortages.
Spotlight
Advocating for patients before Congress
In 2024, Gene Cavacini, senior vice president and chief operating officer for U.S. Pharmaceutical, delivered testimony on behalf of McKesson to the United States House Committee on Ways & Means. The hearing aimed to shed light on supply chain dynamics and offer policy recommendations.
Click the link below to find more information about our lobbying activities, policies and expenditures.
Our work related to supplier diversity is another illustration of our commitment to inclusion.
Our Enterprise Supplier Diversity Program aligns with our purpose of Advancing Health Outcomes for All® by fostering inclusivity and growth opportunities for suppliers. The program seeks to promote equitable consideration for opportunities for qualified businesses, and supports the economic growth and development of the communities in which they operate and serve.